CWM, LLC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 99 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
CWM, LLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$185
+203.6%
0.00%
Q4 2021$0
-100.0%
28
-49.1%
0.00%
Q2 2021$1,0000.0%550.0%0.00%
Q1 2021$1,0000.0%550.0%0.00%
Q4 2020$1,0000.0%550.0%0.00%
Q3 2020$1,0000.0%550.0%0.00%
Q2 2020$1,0000.0%550.0%0.00%
Q1 2020$1,0000.0%550.0%0.00%
Q4 2019$1,0000.0%550.0%0.00%
Q3 2019$1,0000.0%550.0%0.00%
Q2 2019$1,0000.0%550.0%0.00%
Q1 2019$1,000550.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 600,000$8,988,0001.31%
Rubric Capital Management LP 1,569,503$23,511,1551.02%
SPHERA FUNDS MANAGEMENT LTD. 307,283$4,603,0990.99%
HHLR ADVISORS, LTD. 2,623,924$39,306,3820.83%
Parkman Healthcare Partners LLC 191,307$2,865,7790.76%
AlphaCentric Advisors LLC 45,000$674,1000.67%
RICE HALL JAMES & ASSOCIATES, LLC 697,162$10,443,4870.60%
Lion Point Capital, LP 346,500$3,689,0000.52%
EAM Global Investors LLC 116,864$1,750,6230.45%
Jackson Creek Investment Advisors LLC 61,609$9230.41%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders